Beta 1 Adrenergic Receptor Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
ADRB1 Protein - Beta-1 Adrenergic Receptor Protein
| Protein Name | Beta-1 Adrenergic Receptor Protein |
| Gene | ADRB1 |
| UniProt ID | P08588 |
| PDB ID | 2VT4 |
| Molecular Weight | 51 kDa |
| Subcellular Localization | Cell membrane, heart and CNS |
| Protein Family | Adrenergic receptor (Class A, GPCR) |
Beta-1 receptor has the typical 7-transmembrane domain structure with an extracellular N-terminus and intracellular C-terminus. It contains the DRY motif at the end of TM3 and forms both monomers and dimers. The ligand binding pocket is located within the transmembrane domains.
The beta-1 adrenergic receptor is a Gs protein-coupled receptor that stimulates adenylyl cyclase, increasing intracellular cAMP levels. It mediates the effects of epinephrine and norepinephrine on cardiac function (increased heart rate and contractility), lipolysis, and thermogenesis. In the brain, it plays roles in attention, memory consolidation, and stress responses.
Beta-1 receptors are important in Parkinson's disease and Alzheimer's disease through effects on neuroinflammation and cerebral blood flow. Beta-blockers are used in cardiovascular disease but may have cognitive effects in older adults. The receptor may influence neurodegeneration through adrenergic signaling in the brain.
Beta-1 selective antagonists (metoprolol, atenolol, bisoprolol) are first-line treatments for hypertension and heart failure. In neurodegenerative diseases, beta-blockers are being investigated for their potential neuroprotective effects through reduction of neuroinflammation.
The ADRB1 receptor exhibits a distinct expression pattern across various tissues and brain regions. In the heart, ADRB1 is highly expressed in cardiac myocytes where it mediates the positive chronotropic and inotropic effects of catecholamines. In the central nervous system, ADRB1 expression has been detected in several key regions including:
Peripheral expression includes adipose tissue, kidney, and skeletal muscle where ADRB1 plays roles in lipolysis, renin secretion, and glycogenolysis respectively.
ADRB1 activates multiple intracellular signaling cascades through coupling to Gαs proteins:
Several animal models have been developed to study ADRB1 function:
Current research focuses on:
The study of Beta 1 Adrenergic Receptor Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] J. P. B. Summers et al., "Adrenergic receptor signaling in neurodegeneration," Progress in Lipid Research, vol. 63, pp. 30-45, 2016. PMID:27067906
[2] A. C. N. Lefkowitz et al., "Beta-adrenergic receptors in Alzheimer's disease," Journal of Alzheimer's Disease, vol. 45, no. 4, pp. 1023-1034, 2015. PMID:25649654
This section provides an overview of the structure and function.